Calleary, Minister Dara; outstanding public service; commend

2025-2026 Regular Session Introduced by Josh Bonner and 5 co-sponsors

HR 372 requires drug testing for welfare applicants and recipients, aiming to ensure public funds support individuals free from substance abuse.

House Read and Adopted

Purpose and Intent

The Drug Testing for Welfare Recipients Act (HR 372) aims to establish a framework for drug testing individuals who apply for or receive welfare benefits. The primary intent of the bill is to ensure that public assistance funds are allocated to individuals who are not engaged in substance abuse, thereby promoting responsible use of taxpayer dollars.

Key Provisions

Drug Testing Requirement: The bill mandates that individuals applying for welfare benefits undergo drug testing. This requirement would apply to both initial applicants and current recipients of welfare assistance.

Testing Procedures: The legislation outlines specific procedures for conducting drug tests, including the types of substances to be tested and the protocols for administering tests.

Consequences for Positive Tests: Individuals who test positive for controlled substances may face consequences, which could include temporary suspension of benefits, mandatory participation in a substance abuse treatment program, or other measures aimed at rehabilitation.

Funding and Implementation: The bill may include provisions for funding the drug testing program, although specific dollar amounts and funding sources have not been detailed in the current version.

Affected Parties

Welfare Recipients: The primary group affected by this legislation would be individuals and families receiving welfare benefits, as they would be subject to drug testing requirements.

State Agencies: State welfare agencies would be responsible for implementing the drug testing program, which may require additional resources and training.

Taxpayers: The bill is positioned as a measure to protect taxpayer interests by ensuring that welfare funds are used appropriately.

Legislative Timeline

Introduced: January 13, 2025

The bill was introduced in the House and referred to the Committee on Ways and Means, as well as the Committees on Agriculture and Financial Services for further consideration.

Referred to Subcommittee: February 20, 2025

The bill was referred to the Subcommittee on Nutrition and Foreign Agriculture for detailed examination and discussion.

Conclusion

HR 372 seeks to implement drug testing for welfare recipients as a means to ensure responsible use of public funds. While the bill is still in the early stages of the legislative process, its potential implications for welfare recipients and state agencies could be significant. As the bill progresses through committee reviews, further details regarding its provisions and funding mechanisms may be clarified.

Bill